11
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      School Closures and Social Anxiety During the COVID-19 Pandemic

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In their recent systematic review, Loades et al. 1 reported on the effects that social isolation and loneliness may have on children and adolescents during the global coronavirus disease 2019 (COVID-19) pandemic, with their findings suggesting associations between social anxiety and loneliness/social isolation. While this is undoubtedly true for many individuals, it is also worth commenting upon the subset of children and youth with social phobia for whom a temporary lessening of distress may be observed while schools are closed due to a lack of exposure to anxiety-provoking situations in the school environment. Exposure to feared situations is generally regarded as an essential component of anxiety treatment. 2 School environments typically provide a plethora of opportunities for social exposure. Needless to say, opportunities for exposure to social situations have been exceedingly limited for many children and youth during the COVID-19 outbreak. Furthermore, in many jurisdictions, citizens are being commended by politicians and public health officials for engaging in practices aimed at mitigating viral spread, including physical distancing and avoiding non-essential travel outside of their homes. 3 As a result, individuals with social anxiety disorder are receiving positive reinforcement for avoiding the very situations to which psychological treatment would encourage exposure. In addition, avoidance begets further avoidance by way of negative reinforcement. 4 and acute destabilization for socially anxious children and youth is foreseeable when schools re-open and attendance is expected. Loades et al. aptly acknowledged the limitations of extrapolating existing evidence to the current context. Indeed, the mixture of limited opportunities for social exposure, combined with aspects of both positive and negative reinforcement for avoidance of exposure, highlights the uniqueness of circumstances resulting from the COVID-19 pandemic. Despite pragmatic challenges imposed by the COVID-19 outbreak, it is imperative that treatment of social anxiety disorder continue during the pandemic. Clinicians employing cognitive behavioral therapy may consider shifting their interventions to address negative beliefs and processing of events, rather than emphasizing exposure. Creative and innovative treatment strategies are also called for. Loades et al. suggested that digital interventions may facilitate treatment for children and youth during times of social isolation. Indeed, health care providers in various fields are increasingly turning to virtual care technologies to limit physical meetings between patients and clinicians to mitigate viral spread. 5 In treating social anxiety, clinicians should consider exposure to social and performance situations using virtual means. Clinicians may be lulled into a false sense of security when socially anxious children and youth report improvement concurrent with school closures. However, this does not obviate the need for continued treatment during the pandemic. Such improvement is likely to be short-lived and individuals with social anxiety disorder will face significant challenges when schools re-open, highlighting the need for continued treatment during the pandemic.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19

          Objective Disease containment of COVID-19 has necessitated widespread social isolation. We aimed to establish what is known about how loneliness and disease containment measures impact on the mental health in children and adolescents. Method For this rapid review, we searched MEDLINE, PSYCHINFO, and Web of Science for articles published between 01/01/1946 and 03/29/2020. 20% of articles were double screened using pre-defined criteria and 20% of data was double extracted for quality assurance. Results 83 articles (80 studies) met inclusion criteria. Of these, 63 studies reported on the impact of social isolation and loneliness on the mental health of previously healthy children and adolescents (n=51,576; mean age 15.3) 61 studies were observational; 18 were longitudinal and 43 cross sectional studies assessing self-reported loneliness in healthy children and adolescents. One of these studies was a retrospective investigation after a pandemic. Two studies evaluated interventions. Studies had a high risk of bias although longitudinal studies were of better methodological quality. Social isolation and loneliness increased the risk of depression, and possibly anxiety at the time loneliness was measured and between 0.25 to 9 years later. Duration of loneliness was more strongly correlated with mental health symptoms than intensity of loneliness. Conclusion Children and adolescents are probably more likely to experience high rates of depression and probably anxiety during and after enforced isolation ends. This may increase as enforced isolation continues. Clinical services should offer preventative support and early intervention where possible and be prepared for an increase in mental health problems.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Virtual health care in the era of COVID-19

            Patients are under lockdown and health workers are at risk of infection. Paul Webster reports on how telemedicine is being embraced like never before. In the face of a surge in cases of coronavirus disease 2019 (COVID-19), physicians and health systems worldwide are racing to adopt virtualised treatment approaches that obviate the need for physical meetings between patients and health providers. But many doctors are watching warily. “I'd estimate that the majority of patient consultations in the United States are now happening virtually”, says Ray Dorsey, director of the Center for Health and Technology at the University of Rochester Medical Center (Rochester, NY, USA). “There has been something like a ten-fold increase in the last couple of weeks. It's as big a transformation as any ever before in the history of US health care. But the real question is whether these measures will stay in place after the pandemic subsides?” In shifting towards virtualised care in response to COVID-19, health-care planners worldwide are drawing from China's experiences. In China, patients were advised to seek physicians' help online rather than in person after the pandemic first emerged in Wuhan in December, says Yanwu Xu, principal health architect for Baidu Health, one of China's largest internet corporations, and one of three companies contracted by the Chinese Government to implement virtual care technologies. © 2020 TPG/Getty Images 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Speaking to The Lancet from Beijing, Xu, who is a member of WHO's Digital Health Technical Advisory Group, and a researcher at the Chinese Academy of Sciences' Ningbo Institute of Materials Technology & Engineering, explained that China's virtual care transformation was unleashed when the country's national health insurance agency agreed to pay for virtual care consultations because the hospitals and clinics were full. “For the first time, Chinese physicians have really embraced virtual care”, says Xu. “Thanks to these technologies physicians can consult with upwards of a hundred patients a day, which is a very significant increase in the daily caseloads they handled in person in the past.” Following China's example, on March 30, at the direction of US President Donald Trump, the Centers for Medicare & Medicaid Services (CMS), which oversees the nation's major public health programmes, issued what it termed “an unprecedented array of temporary regulatory waivers and new rules to equip the American healthcare system with maximum flexibility to respond to the 2019 Novel Coronavirus (COVID-19) pandemic”. In a press release, the CMS explained that its new measures will allow for more than 80 additional services to be furnished via telehealth. “During the public health emergencies, individuals can use interactive apps with audio and video capabilities to visit with their clinician for an even broader range of services. Providers also can evaluate beneficiaries who have audio phones only. These temporary changes will ensure that patients have access to physicians and other providers while remaining safely at home.” Eric Topol, director of the Scripps Research Translational Institute in La Jolla (CA, USA), praises these efforts, but laments that they have been so long coming. “This is a very big moment for virtual health care. But, of course, there isn't a lot of readiness. There are so many ways to monitor people's health that we aren't doing at any scale, in large part due to interstate regulatory barriers that have meant we are in no way ready for this moment.” Similar steps to sweep aside regulatory and hegemonic professional barriers are being taken in Canada, according to Sandy Buchman, president of the Canadian Medical Association. “As we confront [COVID-19], we're racing to implement virtual health-care technologies as quickly as we can. The scale and pace of change is unprecedented for Canadian health care.” Topol warns that the sudden rush to virtualisation risks diminishing the quality of clinical care. “It's inexpensive and expedient, but it'll never be the same as a physical examination with all of its human qualities of judgment and communication. But with COVID, this is a trade-off we have to accept.” Similar developments are sweeping health care in the UK, says Trisha Greenhalgh, co-director of the Interdisciplinary Research In Health Sciences Unit at Oxford University (Oxford, UK). “We have a research project that has been tracking the use of video conferencing in Scotland over the past 6 months, and in the space of the last 2 weeks we've seen [a] 1000% increase in use”, said Greenhalgh. “It's incredible. [COVID-19] has done what we couldn't do until now, because, suddenly, it's not just the patient who might die—now it's the doctor who might die. So the doctors are highly motivated. The risk–benefit ratio for virtual health care has massively shifted and all the red tape has suddenly been cut.” In Italy, although all 20 regions had implemented national telemedicine guidelines as of 2018, hospital managers have been largely caught off guard by the explosion in digital demand, says Elena Sini, information officer for GVM Care & Research, a network of nine private hospitals in northern Italy. Many Italian hospitals lack the necessary hardware and technical resources, she noted in a March 23 webinar. “Burnout is also a concern for IT staff, so set up some psychological support for IT staff”, she advises. Sini reported a lack of hardware due to broken supply chains and insufficient bandwidth capacities as the demand increased by about 90% on fixed landlines and 40% on mobile networks in Italy. “We have to ramp up telemedicine capabilities, but for most hospitals in Italy this is an issue. We just don't have the capabilities to deliver.” Speaking alongside Sini, Henning Schneider, chief information officer for Asklepios Kliniken, one of Germany's largest private hospital networks, said the COVID-19 pandemic is highlighting a need for intensified IT collaboration between German hospitals. In New Delhi, India, Anurag Agrawal, director of the Council of Scientific and Industrial Research's Institute of Genomics and Integrative Biology, says Indian health-care providers have become similarly preoccupied with virtual health care while the country is in near-total lockdown. “Suddenly, after years of resistance to virtual health care, our physicians keenly want it”, said Agrawal. “[COVID-19] is breaching the barriers to virtual health care faster than anything in history.” Access to virtual health care is far easier within India's publicly financed health-care systems than among private providers, Agrawal notes. However, as India's response to COVID-19 escalates, many private physicians are providing virtual consultations for free. “That could change if the lockdown runs longer”, Agrawal explains. “Meanwhile, the national and state governments will need some time to ramp this up, and the lockdown is buying us time.” To expedite the transformation, he adds, the Indian Government is copying China's tactics by releasing a set of newly developed applications that use instant messaging platforms, such as WhatsApp, to enable a suite of virtual health-care services, including public messaging about behavioural modifications, epidemiological tracing, and access to virtual health-care providers. “The Chinese had a national advantage with their WeChat messaging platform, which is better-suited to hosting virtual health-care apps than WhatsApp is.” Like Topol, Agrawal warns that virtual health care comes with a trade-off in the quality of patient care. “Physicians, too, we should keep in mind, benefit from the in-person consultations as much as patients”, he suggests. “We may mourn that.” African health-care providers have yet to join the global rush en masse, observes Chris Seebregts, chief executive of Jembi Health Systems, a Cape Town-based non-governmental organisation that advises health-system strategists in digital technologies in Cameroon, Ethiopia, Kenya, Malawi, Mozambique, South Africa, South Sudan, and Uganda. “Digital health technologies are being adopted at a huge rate now here in South Africa in response to [COVID-19]”, Seebregts said via video conference from Cape Town, “but we're not seeing much adoption yet elsewhere in Africa. [COVID-19] may accelerate it, but it's too soon to say.” With mobile phone use now globally ubiquitous, technological barriers to the adoption of virtual health care are easily surmountable, even in the most resource-scarce settings, notes Alex Jadad, founder of the Centre for Global eHealth Innovation at the University of Toronto, ON, Canada, where he is the director of the Institute for Global Health Equity and Innovation. “Whether I'm deep in Malawi or deep in the Amazon, all I need is a mobile phone and a connection that allows me to talk to a clinician. That's all it takes for a clinical encounter. These are god-like tools for medicine. There's no need for us to wait for any more sophisticated infrastructure than that”, says Jadad, who is advising on virtual health-care adoption strategies for health groups in Colombia. “The regulatory barriers that have held virtual health care back for all these decades were never justifiable”, Jadad avers. “[COVID-19] is an opportunity to blow all these barriers away. And the question now is ‘how far are we willing to go?’” © 2020 Catherine Lai/AFP/Getty Images 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Cognitive Behavioral Therapy for Childhood Anxiety Disorders: a Review of Recent Advances

                Bookmark

                Author and article information

                Journal
                J Am Acad Child Adolesc Psychiatry
                J Am Acad Child Adolesc Psychiatry
                Journal of the American Academy of Child and Adolescent Psychiatry
                American Academy of Child and Adolescent Psychiatry
                0890-8567
                1527-5418
                2 September 2020
                2 September 2020
                Affiliations
                [1]University of Alberta, Edmonton, Alberta, Canada
                Author notes
                []Correspondence to Matthew Morrissette, MD, 1E1, 8440 112 St NW, Edmonton, Alberta, Canada T6G 2B7;
                Article
                S0890-8567(20)31838-4
                10.1016/j.jaac.2020.08.436
                7467010
                32890669
                c810c82a-3fa0-4372-a042-736787870356
                © 2020 American Academy of Child and Adolescent Psychiatry.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 30 June 2020
                : 13 August 2020
                : 20 August 2020
                Categories
                Article

                Clinical Psychology & Psychiatry
                Clinical Psychology & Psychiatry

                Comments

                Comment on this article